In our quest to develop new drug delivery systems, we designed and synthesized PEG-conjugates and PEG-hydrogels with a degradable linkage to the drug. Specifically, methoxyPEG-doxorubicin (MPEG-CH=N-Doxo) and doxorubicin-PEG aldehyde (OHC-PEG-CH=N-Doxo) conjugates, plus poly (vinyl amine)-PEG-doxorubicin (PVAm-PEG-Doxo) hydrogels were prepared. The hydrogels were crosslinked by PEG-Schiff base linkages, and the Doxo was conjugated to the gel by pendant Schiff base bonds (PVAm-N=CH-PEG-CH=N-Doxo). The release profile of Doxo from the hydrogels was dependent on pH and on the ratio of PVAm to the PEG-dialdehyde crosslinker. These degradable PEG hydrogels could be good candidates for slow release of Doxo from subcutaneous or IM implants.
Merrill, E.W. and Salzman, E.W. (1983). Polyethylene Oxide as a Biomaterial, ASAIO J, 6: 60—64.
2.
Harris, J.M. and Zalipsky, S. (eds). (1997). Poly(ethylene glycol) Chemistry and Biological Applications, ACS Symposium Series 680, ACS, Washington, DC.
3.
Harris, J.M. , Martin, N.E. and Modi, M. (2001). PEGylation: A Novel Process for Modifying Pharmacokinetics , Clin Pharmacokinet., 40: 539—551.
4.
Hinds, K.D. and Kim, S.W. (2002). Effects of PEG Conjugation on Insulin Properties , Adv Drug Deliv Rev, 54: 505—530.
5.
Maeda, H. (2001). The Enhanced Permeability and Retention (EPR) Effect in Tumor Vasculature: the Key Role of Tumor-selective Macromolecular Drug Targeting, Adv Enzyme Regul, 41: 189—207.
6.
Bailon, P. and Berthold, W. (1998). Polyethylene Glycol-conjugated Pharmaceutical Proteins, Pharm Sci Technol Today, 1: 352—356.
7.
Harris, J.M. and Chess, R.B. (2003). Effect of PEGylation on Pharmaceuticals, Nat Rev Drug Discov, 2: 214—221.
8.
Duncan, R. (2006). Polymer Conjugates as Anticancer Nanomedicines , Nat Rev Cancer, 6: 688—701.
9.
Zalipsky, S. (1995). Functionalized Poly(ethylene glycol) for Preparation of Biologically Relevant Conjugates, Bioconjug Chem, 6: 150—165.
10.
Zalipsky, S. (1995). Chemistry of Polyethylene Glycol Conjugates with Biologically Active Molecules, Adv Drug Deliv Rev, 16: 157—182.
11.
Veronese, F.M. (2001). Peptide and Protein PEGylation: a Review of Problems and Solutions, Biomaterials, 22: 405—417.
12.
Roberts, M.J. , Bentley, M.D. and Harris, J.M. (2002). Chemistry for Peptide and Protein PEGylation, Adv Drug Deliv Rev, 54: 459—476.
13.
Roberts, M.J. and Harris, J.M. (1998). Attachment of Degradable Poly(ethylene glycol) to Proteins Has the Potential to Increase Therapeutic Efficacy, J Pharm Sci, 87: 1440—1445.
14.
Kratz, F., Beyer, U. and Schutte, M.T. (1999). Drug-polymer Conjugates Containing Acid-cleavable Bonds, Crit Rev Ther Drug Carrier Syst, 16: 245—288.
15.
Murthy, N., Campbell, J., Fausto, N., Hoffman, A.S. and Stayton, P.S. (2003). Design and Synthesis of pH-responsive Polymeric Carriers that Target Uptake and Enhance the Intracellular Delivery of Oligonucleotides , J Contr Rel, 89: 365—374.
16.
Murthy, N., Campbell, J., Fausto, N., Hoffman, A.S. and Stayton, P.S. (2003). Bioinspired pH-responsive Polymers for the Intracellular Delivery of Biomolecular Drugs, Bioconjug Chem, 14: 412—419.
17.
Etrych, T., Jelinkova, M., Rihova, B. and Ulbrich, K. (2001). New HPMA Copolymers Containing Doxorubicin Bound via pH-sensitive Linkage: Synthesis and Preliminary In Vitro and In Vivo Biological Properties, J Contr Rel, 73: 89—102.
18.
Ulbrich, K. and Subr, V. (2004). Polymeric Anticancer Drugs with pH-controlled Activation, Adv Drug Deliv Rev, 56: 1023—1050.
19.
Yoo, H.S. , Lee, E.A., and Park, T.G. (2002). Doxorubicin-conjugated Biodegradable Polymeric Micelles Having Acid-cleavable Linkages, J Contr Rel, 82: 17—27.
20.
Duncan, R., Kopeckova-Rejmanova, P., Strohalm, J., Hume, I., Cable, H.C., Pohl, J., Lloyd, J.B. and Kopecek, J. (1987). Anticancer Agents Coupled to N-(2-Hydroxypropyl) Methacrylamide Copolymers. 1. Evaluation of Daunomycin and Puromycin Conjugates In Vitro, BritJ Cancer, 55: 165—174.
21.
Duncan, R., Hume, I., Kopeckova, P., Ulbrich, K., Strohalm, J. and Kopecek, J. (1989). Anticancer Agents Coupled to N-(2-Hydroxypropyl) Methacrylamide Copolymers. 3. Evaluation of Adriamycin Conjugates Against Mouse Leukemia L1210 In Vivo, J Contr Rel, 10: 51—63.
22.
Cuchelkar, V. and Kopecek, J. (2006). Polymer-Drug Conjugates , In: Uchegbu, I.F. and Schatzlein, A.G. (Eds), Polymers in Drug Delivery , pp. 155—182, CRC Press, Boca Raton, FL.
23.
Bulmus, E.V. , Woodward, M., Lin , L., Murthy, N., Stayton, P.S. and Hoffman, A.S. (2003). A New pH-responsive and Glutathione-reactive, Endosomal Membrane-disruptive Polymeric Carrier for Intracellular Delivery of Biomolecular Drugs, J Contr Rel, 93: 105—120.
24.
Ohya, Y., Kuroda, H., Hirai, K. and Ouchi, T. (1995). Synthesis and Cytotoxic Activity of Conjugates of Monomethoxy-poly-(ethylene glycol) End-capped with Doxorubicin via Ester, Amide, or Schiff's Base Bond, J Bioactive and CompatPolym , 10: 51—66.
25.
Murakami, Y. , Yokoyama, M., Okano , T., Nishida, H., Tomizawa, Y., Endo, M. and Kurosawa, H. (2007). A Novel Synthetic Tissue-adhesive Hydrogel Using a Crosslinkable Polymeric Micelle, J Biomed Mater Res A, 80: 421—427.
